Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 16122901 | BML-210 | 537034-17-6 | 98% |  |
| BML-210, also known as CAY10433, is HDAC inhibitor. BML-210 induces growth inhibition | ||||
| 16122868 | BIIB021 | 848695-25-0 | 98% |  |
| BIIB021, also known as CNF2024, is an orally active, purine-scaffold, small-molecule | ||||
| 16122867 | BI605906 | 960293-88-3 | 98% |  |
| BI605906 is a IKK inhibitor. BI605906 inhibits TNF-dependent IB degradation and expre | ||||
| 16122866 | Benzbromarone | 3562-84-3 | 98% |  |
| Benzbromarone is a uricosuric agent and non-competitive inhibitor of xanthine oxidase | ||||
| 16122805 | BAY-59-3074 | 406205-74-1 | 98% |  |
| BAY-59-3074 is a novel cannabinoid CB1/CB2 receptor partial agonist with analgesic pr | ||||
| 16122804 | Batimastat | 130370-60-4 | 98% |  |
| Batimastat (also known as BB-94) is a synthetic matrix metalloproteinase inhibitor th | ||||
| 16122778 | BFH772 | 890128-81-1 | 98% |  |
| BFH772 is a novel potent oral VEGFR2 inhibitor, targeting VEGFR2 kinase with IC50 of | ||||
| 16122776 | BI-78D3 | 883065-90-5 | 98% |  |
| BI-78D3 is a competitive JNK inhibitor with IC50 of 280nM that displays > 100 fold | ||||
| 16122769 | BDA-366 | 1909226-00-1 | 98% | |
| BDA-366 is a small-molecule Bcl2-BH4 domain antagonist and binds BH4 with high affini | ||||
| 16122742 | BI-7273 | 1883429-21-7 | 98% | |
| BI-7273 is a potent, selective, and cell-permeable BRD9 BD Inhibitor. | ||||
| 16122740 | BI-9564 | 1883429-22-8 | 98% | |
| BI-9564 is a selective inhibitor of BRD9 and BRD7 bromodomains with the IC50 of 75 nM | ||||
| 16122733 | BAW2881 (NVP-BAW2881) | 861875-60-7 | 98% | |
| BAW2881 (NVP-BAW2881) is a novel vascular endothelial growth factor (VEGF) receptor t | ||||
| 6111507 | BMS-983970 | 1584713-87-0 | 98% | |
| BMS-983970 is an oral pan-Notch inhibitor for the treatment of cancer. | ||||
| 6111415 | BAY-61-3606 | 648903-57-5 | 98% |  |
| BAY-61-3606 is a potent and selective inhibitor of Syk kinase (Ki = 7.5 nM). | ||||
| 61402 | BH3I-1 | 300817-68-9 | 98% |  |
| BH3I-1 is an inhibitor of Bcl-xL with IC 50 of 293.95 M. BH3I-1 is a cell permeable B | ||||
| 61401 | Bax inhibitor peptide V5 | 579492-81-2 | 98% |  |
| Bax inhibitor peptide V5 is a peptide inhibitor of Bax translocation to mitochondria. | ||||
| 61122 | BMS-986020 | 1257213-50-5 | 98% |  |
| BMS-986020 is a lysophosphatidic acid 1 receptor antagonist. BMS-986020 is in Phase 2 | ||||
| 6111106 | (±)-Bisoprolol hemifumarate | 104344-23-2 | 98% | -Bisoprololhemifumarate-cas-104344-23-2.png) |
| Bisoprolol is a selective type 1 adrenergic receptor blocker.Bisoprolol, on beta 1-ad | ||||
| 6111023 | BNC105 | 945771-74-4 | 98% |  |
| BNC105 is a tubulin polymerization inhibitor with potent antiproliferative and tumor | ||||
| 6111002 | 6-bromo-[1,2,4]triazolo[1,5-a]pyridine | 356560-80-0 | 98% |  |
| 6-bromo-[1,2,4]triazolo[1,5-a]pyridine | ||||
| 611917 | Briciclib | 865783-99-9 | 98% |  |
| Briciclib is a small molecule that suppresses cyclin D1 accumulation in cancer cells. | ||||
| 1681202 | 3-bromo-1-ethyl-1H-pyrrole-2,5-dione | 909397-54-2 | 98% |  |
| 3-bromo-1-ethyl-1H-pyrrole-2,5-dione,CAS#909397-54-2 | ||||
| 1673102 | Bexagliflozin(EGT1442) | 1118567-05-7 | 98% by HNMR/HPLC | -cas-1118567-05-7.png) |
| EGT1442, a potent and selective SGLT2 inhibitor, attenuates blood glucose and HbA(1c) | ||||
| 16071105 | BCX-1777 | 209799-67-7 | 98% by HPLC |  |
| BCX-1777 | ||||
| 16071031 | BYK204165 | 1104546-89-5 | 98% by HPLC |  |
| BYK204165 is a potent and selective poly(ADP-ribose) polymerase (PARP)-1 inhibitor (p | ||||
| 16071026 | BMS-3 | 1338247-30-5 | 98% by HPLC |  |
| BMS-3 is a LIM kinase 1 (LIMK1) inhibitor. LIMK inhibition with 1 M BMS-3 damaged MTO | ||||
| 16071006 | BAM 7 | 331244-89-4 | 98% by HPLC |  |
| BAM 7 is a Bax activator (EC50 = 3.3 M). BCL-2 family proteins are key regulators of | ||||
| 16071005 | BTZ043 | 957217-65-1 | 98% by HPLC |  |
| BTZ043 racemate is adecaprenylphosphoryl--D-ribose 2'-epimerase (DprE1)inhibitor acti | ||||
| 16070108 | Bromosporine | 1619994-69-2 | 98% by HPLC |  |
| Bromosporine is a broad spectrum inhibitor for bromodomains and as such will be very | ||||
| 16062903 | BMS-582949 | 623152-17-0 | 98% by HPLC |  |
| BMS-582949 is a potent and selective P38 mitogen-activated protein kinase (P38 MAPK) | ||||